A new pill to treat HIV infection, combining two previously approved drugs plus two new ones, has been approved for adults living with the virus that causes AIDS, US regulators said on Monday.
The single daily dose of Stribild provides a complete treatment regimen for HIV infection, the US Food and Drug Administ-ration said in a statement, and is meant for people who have not already received treatment with other HIV drugs. “Through continued research and drug development, treatment for those infected with HIV has evolved from multi-pill regimens to single-pill regimens,” said Edward Cox, director of the Office of Antimicrobial Products in the FDA’s Cen-tre for Drug Evaluation and Research.
***
Breast cancer may recur in obese women
Washington: Among women who have been treated for breast cancer, heavier women are more likely to have their disease come back and more likely to die of cancer, according to a US study.
Previous studies have tied obesity to a higher chance of getting breast cancer and a worse outcome in women who have already been diagnosed. But the current study, which appeared in the journal Cancer, makes the post-diagnosis picture clearer, said lead researc-her Joseph Sparano, associate chairman of medical oncology at the Montefiore Einstein Centre for Cancer Care in the Bronx, New York. “Obesity seemed to carry a higher risk of breast cancer recurrence and death, even in women who were healthy at the time that they were diagnosed, and despite the fact that they received the best available chemotherapy and hormone therapy,” he said. — Reuters